ALLMedicine™ Respiratory Failure Center

Sep 15th, 2021 - Respiratory failure from acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is associated with high mortality. Direct hemoperfusion with polymyxin B-immobilized fiber column (PMX-DHP) has been reported to have beneficial effects on patie...

Sep 15th, 2021 - Patients with combined circulatory shock and respiratory failure may benefit from veno-arteriovenous (V-AV) extracorporeal membrane oxygenation support (ECMO). We report our center's experience with V-AV ECMO and propose an algorithm to help ident...

Sep 13th, 2021 - We aimed to identify associations between the risk of acute respiratory failure (ARF) and types of antihypertensive agents in patients with viral pneumonia. In this case-control study, data extracted from the Taiwan National Health Insurance Resea...

Sep 11th, 2021 - To find risk markers and develop new clinical predictive models for the differential diagnosis of hand-foot-and-mouth disease (HFMD) with varying degrees of disease. 19766 children with HFMD and 64 clinical indexes were included in this study. The...

Sep 11th, 2021 - Prediction of high flow nasal cannula (HFNC) failure in COVID-19 patients with acute hypoxemic respiratory failure (AHRF) may improve clinical management and stratification of patients for optimal treatment. We performed a systematic review and me...

Jun 9th, 2021 - The imbalance between the prevalence of patients with acute respiratory failure (ARF) and acute-on-chronic respiratory failure and the number of intensive care unit (ICU) beds requires new solutions. The increasing use of non-invasive respiratory ...

Apr 27th, 2021 - The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of high-flow nasal oxygen (HFNO) in hospitalized patients for initial or postextubation management of acute respiratory fa...

Dec 11th, 2020 - Mechanical ventilation (MV) is an essential part of modern intensive care medicine. MV is performed in patients with severe respiratory failure caused by respiratory muscle insufficiency and/or lung parenchymal disease; that is, when other treatme...

Dec 11th, 2020 - Long-term mechanical ventilation is a well-established treatment for chronic hypercapnic respiratory failure (CHRF). It is aimed at improving CHRF-related symptoms, health-related quality of life, survival, and decreasing hospital admissions. In S...

Jul 24th, 2020 - This guideline describes prolonged extracorporeal life support (ECLS) and extracorporeal membrane oxygenation (ECMO), applicable to Pediatric respiratory failure. These guidelines describe useful and safe practice, prepared by ELSO and based on ex...

Sep 9th, 2021 - Recently, high flow oxygen therapy (HFOT) is becoming more popular in the treatment of any kind of respiratory failure. Pediatric mechanical ventilation consensus conference (PEMVECC) guidelines suggest measuring oxygen saturation by pulse oximetr...

Sep 8th, 2021 - Detailed Description: Attack of the Alveolar Type II (ATII) cell via its ACE2 surface receptor by the SARS-CoV-2 virus leads to respiratory failure, morbidity, and frequently mortality in COVID-19. There is no approved treatment that specifically ...

Sep 8th, 2021 - Background: Patients infected with COVID-19 have an unpredictable risk to worsen and die, making it difficult to decide who can quarantine at home and who should be monitored for respiratory failure as an inpatient. This risk may be related in par...

Sep 8th, 2021 - A preparation of CimertA (Botanical Drug), comprising Curcumin, Boswellia, and Vitamin C in a nanoparticular formulation, is proposed as a treatment for the disease associated with the novel corona virus SARS-CoV-2. This initiative is presented un...

Sep 1st, 2021 - The first aim of this project is to determine whether rapidly assayed early clinical laboratory markers of CSS (eCSS: leucopenia, lymphopenia, and elevated ferritin, d-dimer, LDH, CRP, and AST/ALT) in patients admitted to the hospital with respira...

Jul 20th, 2021 - (Reuters) - Europe's medicines regulator is evaluating an application to use an arthritis drug developed by Sweden's Sobi to treat COVID-19 in adults with pneumonia who are at risk of severe respiratory failure, the agency said on Monday. The rheu...

Jul 6th, 2021 - Myasthenia gravis (MG) is a relatively rare autoimmune disorder in which antibodies form against nicotinic acetylcholine (ACh) postsynaptic receptors at the neuromuscular junction of the skeletal muscles. It is a type II hypersensitivity immune re...

Jun 30th, 2021 - The fixed combination of daunorubicin and cytarabine (CPX-351; Vyxeos) continued to demonstrate improved overall survival (OS) vs 7+3 chemotherapy in older patients with newly diagnosed high-risk or secondary acute myeloid leukemia (AML), accordin...

Jun 30th, 2021 - Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare but serious sensorimotor disorder that is presumed to result from a probable immunologic antibody-mediated reaction, along with interstitial and perivascular infiltration o...

Jun 11th, 2021 - Zanubrutinib (Brukinsa) continued to induce deep responses with acceptable tolerability in patients with relapsed/refractory chronic lymphocytic leukemia (CLL), including those with high-risk cytogenetics, according to long-term data from the phas...